Suppressor of cytokine signaling 3 (SOCS3) expression in bone marrow cells (BMC) was up-regulated upon exposure to interleukin 6, lipopolysaccharide, or tumor-associated factors.
Introduction
Suppressor of cytokine signaling 3 (SOCS3), alternatively called cytokine-inducible SH2-containing protein-3, belongs to the SOCS family of proteins. SOCS3 contains an NH 2 terminal region, a central SH2 domain, and a COOH terminal motif called the SOCS box (1, 2) . The SH2 domain is responsible for direct or competitive inhibition of signaling proteins by interacting with the Janusactivated kinases (JAK) or blocking signal transducers and activators of transcription (STAT) access to docking sites on the receptors (2) . SOCS box is thought to be involved in protein degradation via the ubiquitin-proteasome pathway (3) . Recently, Babon and colleagues (1) described a 35-residue unstructured PEST motif insertion, a sequence rich in Pro, Glu (and Asp), Ser, and Thr, which increases SOCS3 turnover and affects its degradation pathway (1) . Thus, SOCS3 protein possesses several functional regions to regulate cellular growth, development, differentiation, and survival through multiple pathways. SOCS3 has been shown to specifically inhibit signaling by IFN-g, interleukin-6 (IL-6) family of cytokines (4) (5) (6) (7) , and can act as a negative regulator of inflammatory responses (8, 9) . It is a critical regulator of cytokine signaling and JAK/STAT pathway (10) .
Unlike with SOCS1(11), the studies of SOCS3 for its effect on the differentiation of hematopoietic cells was hindered because mice lacking SOCS3 die during embryogenesis as the result of a placental defect by an enhanced activation of the leukemia inhibitory factor signaling pathway (7, 12) . However, SOCS3 has been shown as a physiologic negative regulator for granulopoiesis, granulocyte colony-stimulating factor receptor signaling (13) . SOCS3 is also essential in the regulation of fetal liver erythropoiesis (14) . Because SOCS3 is selectively expressed in Th2 cells (15, 16) , the role of SOCS3 in Th2 cell biology has also been assessed by transgenic mice made using MyC-tagged SOCS3 (16) . The conditional knockout (SOCS3 is absent only in mammary gland, salivary gland, seminal vesicle, skin, B cells, and T cells) studies show that SOCS3 is an essential negative regulator of IL-23 signaling, which constrains the generation of Th17 differentiation (17) . Using DeltaLck/DeltaLck mice, which lack SOCS3 in T/natural killer T cells, Brender and colleagues found that SOCS3-deficient CD8 T cells showed greater proliferation than wild-type cells in response to T-cell receptor (TCR) ligation despite normal activation of signaling pathways downstream from TCR or CD28 receptors (18) . Thus, SOCS3 indeed plays an important role not only in the differentiation of hematopoietic stem cells but also in differentiation of T-cell subsets. SOCS proteins are rapidly induced by cytokines, such as IFN-g, IL-2, IL-3, IL-6, and IL-10, and also lipopolysaccharides (LPS; [19] [20] [21] . We previously reported that tumor-associated factors could promote the expression of SOCS3 in bone marrow-derived dendritic cells (DC; ref. 22) . Here, we found that SOCS3 expression in bone marrow cells (BMC) is also up-regulated by tumor-associated factors, IL-6, and LPS. We hypothesized that elevated SOCS3, upon exposure to some pathologic factors, might affect the differentiation of BMCs. Indeed, studies found that SOCS3 can promote BMCs to differentiate into CD8 + T cells in lung tissue via up-regulating Notch1 expression, likely representing another kind of BMC-based immune response against diseases. the following antibodies: FITC-conjugated or PE-conjugated anti-TCR ah (H57-597), CD4 (L3T4), CD8a (Ly-2), CD11c (N418), CD11b (M1/70), Gr-1 (RB6-8C5), CD19 (1D3), B220 (RA36B2), I-A b (25-9-17) , and MAC-3 (M3/84). All of these antibodies were purchased from BD Bioscience. Cells were then washed twice and resuspended in PBS with 1% paraformadehyde and 1% FCS and kept at 4jC before flow cytometric analysis. For FITC-labeled anti-V5 antibody, the cells were fixed, penetrated, and stained using FITClabeled anti-V5 antibody.
Cocultures of murine BMCs with lung tissue cells or OP9 stromal cells. Murine BMCs were prepared according to previous reported method (24) . RBCs were lysed in hypotonic buffer. CD8 + and CD4 + T and B lymphocytes were deleted using CD4 T cell-positive, CD8 T cell-positive, and B cell-positive selected magnetic beads (MACS) according to the described protocol. After deletion, the ratio of CD4 T cells, CD8 T cells, and B cells in BMCs was <1%. Besides especially indicated, CD4 T cell-free, CD8 T cell-free, and B cell-free BMCs were used in the experiments.
For the preparation of a single lung tissue cell, lung tissue was digested using a modification of the procedure of Corti and colleagues (25) , in which the main stem bronchus was cannulated using a 23-gauge angiocatheter and instilled with 1 mL of dispase (2.4 units/mL; Roche Diagnostics) followed immediately by 1% low-melt agarose in PBS at 42jC. This lung was placed on ice for 2 min, after which it was digested with an additional 1 mL of dispase for 45 min at room temperature, minced in DMEM supplemented with 100 units/mL DNase I (Roche Diagnostics), and passed through a 40-Am filter and a 22-Am nytex mesh (Sefar America). The cells were centrifuged at 800 Â g for 10 min, after which RBCs were lysed. The cells were washed with PBS and resuspended in PBS supplemented with 3% FCS and 5 mmol/L EDTA at 100,000/mL. After CD4 T cells, CD8 T cells, B cells, and sometimes CD11C + DCs, CD11C + B220 + PDCA-1 + DCs (plasmacytoid DCs), or CD11C + MAC-3 + macrophages were deleted using magnetic beads (Miltenyi Biotec, Inc.), the prepared lung tissue cells were used to induce differentiation of BMCs into CD8 + T lymphocytes. Coculture of BMCs with OP9 stromal cell or lung tissue cells were performed according to the reported method (26) . 1 Â 10 6 CD4 T cell-free, CD8 T cell-free, and B cell-free murine BMCs were added per individual sixwell plate confluent with either DP-9-DL1 cells, OP9-control cells kindly provided by Dr. Zuniga-Pflucker (University of Toronto), or lung tissue cells. RPMI 1640 was supplemented with 20% FCS plus 100 units/mL penicillin and streptomycin. Cocultures were disappregated by vigorous pipetting and passaged through a 70-Am filter to reduce stromal cell line aggregates and eliminate contaminating OP9 cells. All cocultures were performed in the presence of 5 ng/mL IL-7 and 5 ng/mL Flt3L (Peprotech).
Transfection and transplantation. Transfection of BMCs from C57BL/ 6 or BALB/c mice with different plasmid structures were performed using nucleofection approach according to the manufacturer's protocol (Amaxa). Transfection efficiency after 24 h may reach 45% (Supplementary Fig. S1 ). Approximately, 1 Â 10 7 cells in 500 AL of PBS were transplanted into lethally irradiated (1,000 rad) 4-wk-old to 6-wk-old female syngeneic recipients through tail blood vessel. Three weeks later, peripheral blood cells, spleen cells, BMCs, and other tissue cells, such as lung tissue cells, were prepared for fluorescence-activated cell sorting analysis by fluorescence staining.
pcDNASOCS3, pcDNASOCS1, and pcDNASOCS3 #129-161 plasmid. pcDNA3.1TOPOV5SOCS3 and pcDNA3.1TOPOV5SOCS1 were constructed by cloning murine SOCS1 and SOCS3 genes using the pcDNA3.1/V5-HisTopo kit according to the manufacturer's protocol (Invitrogen). Primers were used for cloning SOCS1 and SOCS3 (Supplementary Table S1 ). pcDNA contained irrelative sequence ( forward sequence, ACCATGGGATCTGAT AAAGCGGCC) as control structure. SOCS3 mutants lacking aa129-161 (SOCS3Daa129-161) was done by two-step PCR and then cloned into pcDNA using the pcDNA3.1/V5-His-TOPO kit. Primers used were listed in Supplementary Table S1 . Primers 1# and 4# were used to amplify 5 ¶ end fragment. The 2# and 3# primers were used to amplify the 3 ¶ terminal fragment. Primers 1# and 2# were used to amplify the SOCS3 mutants lacking aa129-161. The sequences of cloned SOCS1, SOCS3, and SOCS3Daa129-161 were finally confirmed.
pNK-SOCS3 small interfering RNA vector. pFIV-H1/U6-copGFPdouble promoter-small interfering RNA (siRNA) expression vector (SBI System Biosciences) was used to construct siRNA plasmid, named pNKsiRNA-GFP vector. Double-promoter siRNA cassette was designed using the protocol described at the Ambion site 4 and inserted in pNK-siRNA-GFP expression vector. Specific mSOCS3 sequences targeted include sequence 1#: GAACCTACGCATCCAGTGT and sequence 2#: GCTGGTGCACCACTA-CATG. Specific murine Notch1 sequences targeted include sequence1#: GGAAGCTAAGGACCTCAAG and sequence 2#: GGACATGACCAGTGGC-TAC. The nonsilencing control siRNA is an irrelevant siRNA with random nucleotides (ACTATCTAAGTTACTACCC). Searches of the mouse genome database (BLAST) were carried out to ensure that the sequence would not target other gene transcripts. Cells were transfected with the siRNA structures using mouse immature DC nucleofector kit (Amaxa) according to the manufacturer's protocol. Transfection efficiency after 24 h was over 40% (Supplementary Fig. S1 ).
Reverse transcription-PCR analysis. Total cellular RNA was prepared using TRIzol reagent (Invitrogen) followed by RNA clean up with RNeasy Mini kit (Qiagen), as recommended by the manufacturer. Reverse transcription-PCR (RT-PCR) was performed by SuperScript one-step RT-PCR with platinum Taq according to the protocol provided (Invitrogen). Amplification conditions included cDNA synthesis and predenaturation (one cycle: 50jC for 15 min, 94jC for 2 min), PCR amplification (40 cycles: denature 94jC for 15 s, anneal 55jC for 30 s, extend 72jC for 1 min/kb), and final extension (one cycle: 72jC for 10 min). The primers used were listed in Supplementary Table S1 .
Western blotting analysis. Cells were harvested and washed twice with cold PBS, and 1 Â 10 6 pelleted cells were disrupted on ice in lysis buffer (50 mmol/L HEPES, 150 mmol/L NaCl, 5 mmol/L EDTA, 1 mmol/L NaOV 4 , 0.5% Triton, 0.1 Ag/AL pepstatin, 0.1 Ag/AL antipain, 0.1 Ag/AL aprotinin, 2 mmol/L phenylmethylsulfonyl fluoride). Proteins were separated on a 10% denaturing SDS polyacrylamide gel and transferred on a polyvinylidene difluoride membrane (Millipore). The membrane was saturated for 1 h at room temperature in PBS/0.05% Tween 20 (PBS-T) supplemented with different concentrations of nonfat dried milk (Sigma-Aldrich). Hybridizations of primary antibody were carried out for 1 h at room temperature in blocking buffer and polyclonal rabbit anti-actin antibody (1:500; SigmaAldrich) for 1 h at room temperature in PBS-T/3% bovine serum albumin (BSA). The protein-antibody complexes were detected using the peroxidaseconjugated secondary antibody (Boehringer Mannheim) and enhanced chemiluminescence (Amersham).
Immunohistochemistry. Tissue was frozen in ornithine carbamyl transferase (OCT) compound (Sakura Finetek), cut into 6-Am to 8-Am sections and collected on Frost Plus microscope slides (VWR Scientific). After air drying for at least 2 h, the tissue was immersed for 20 min in cold acetone (À20jC), rinsed in PBS, and then processed for immunofluorescence microscopy. Expression of Notch ligand y-like 1 or y-4 was detected by using the rabbit anti-mouse y-like 1 or y-4 antibodies (Rockland). Secondary horseradish peroxidase-conjugated anti-rabbit antibody was purchased from Santa Cruz and diluted in PBS containing 3% BSA, and 10% normal mouse serum were used to detect protein-antibody complexes. Slides were developed using 3,3 ¶-diaminobenzidine and then stained with hematoxylin. Images were acquired using a Nikon Microphot-SA microscope equipped with a 20Â/0.5Â objective lens and a Nikon FX-35DX camera (Nikon) with SPOT 3.0.2 software (Diagnostic Instruments).
ELISA. Commercial sandwich ELISA kits were used for quantitation of IFNg (Pierce Endogen). The absorbance of each sample was measured at 450 nm using a SpectraMax 190 ELISA plate reader. Cytokine levels were quantified from three titrations using standard curves and expressed in pg/mL.
Results

SOCS3 promotes murine BMCs to differentiate into CD8
+ T lymphocytes. Whereas murine BMCs were exposed to IL-6 and LPS or cocultured with ovarian 1D8 tumor cells and Lewis lung carcinoma in separate chambers (Fig. 1A ), SOCS3 expression of BMCs was remarkably up-regulated in both transcription and protein levels. Because of the critical roles of SOCS3 in regulating intracellular signals, especially cytokine-related signal pathway, we hypothesized that these disease-associated factors up-regulated SOCS3 might affect the differentiation of BMCs. To investigate effect of the elevated SOCS3 on the differentiation of BMCs, we reconstituted the lethally irradiated C57BL/6 mice with T cell-free and B cell-free murine BMCs, which were transfected using SOCS3 structure with high transfection efficiency ( Supplementary Fig. S1 ). Meanwhile, we also reconstituted mice with SOCS1 and control plasmid structure-transfected BMCs as controls. Resultant chimeric mice were subsequently sacrificed at the indicated points after BMC transplantation. The cells from bone marrow, spleen, and blood were examined by flow cytometric analysis. Hemotopoietic Figure 1 . SOCS3 promotes murine BMCs to differentiate into CD8 + T lymphocytes. A, LPS, IL-6, or tumor-associated factors up-regulated SOCS3 expression of murine BMCs. Freshly isolated BMCs (2 Â 10 6 /well) were cultured in medium with 10 ng/mL IL-6 (R&D Systems) or 100 ng/mL LPS (Sigma) for 24 h. Contr., untreated BMCs; Tu.Sup1, BMCs cultured with 1D8 tumor cell in transwell plate for 24 h; Tu.Sup2, BMCs cultured with CT-26 colon cancer cells in transwell plate for 24 h. For transwell analysis, using transwell permeable supports with 3.0-Am pore size (Corning, Inc., Life Sciences), freshly isolated BMCs (1 Â 10 6 /well), and ovarian 1D8 tumor cells or CT-26 colon cancer cells (1 Â 10 4 /insert) were cocultured in separate chambers. SOCS3 and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) transcripts in murine BMCs were determined by RT-PCR (A1.1 and A2.1 ). Protein levels of SOCS3 and actin were determined by Western blot analysis (A1.2 and A2.2 ). Mouse monoclonal anti-SOCS3 (Transduction-Becton Dickinson) was used in Western blotting analysis. B, CD8 + , CD4 + , and CD4 + CD8 + T-cell populations of the peripheral blood from reconstituted C57BL/6 mice with BMCs transfected using pcDNASOCS3 (SOCS3 ), pcDNASOCS1 (SOCS1 ), or control vectors (pcDNA ) after day 21 were analyzed by staining using FITC-labeled anti-CD8 and PE-labeled anti-CD4 antibodies. Numbers in different areas indicate the percentage of CD4 + , CD8 + , CD4 + CD8 + T cells of the murine peripheral blood cells. Contr., untransfected BMCs. C, SOCS3-positive cell population of the peripheral blood CD8 + T lymphocytes from reconstituted C57BL/6 mice with SOCS3-transfected BMCs. SOCS3-positive cell population in the peripheral blood CD8 + T lymphocytes of reconstituted C57BL/6 mice with SOCS3-transfected BMCs were analyzed by flow cytometry after staining using anti-SOCS3 tagged V5 antibody (C1.3 ) or isotypic antibody (C1.2 ). C1.1, the gated peripheral blood cells. CD8 + T cells from reconstituted C57BL/6 mice with BMCs (C2.1 ) and with SOCS3-transfected BMCs (C2.3 ) under light microscope; CD8 + T cells from reconstituted C57BL/6 mice with BMCs (C2.2 ) and with SOCS3-transfected BMCs (C2.4 ) under fluorescent microscope. CD8 + T lymphocytes were separated using CD8 + T cell-positive selected magnetic beads according to the described protocol (MACS). The isolated CD8 T cells were fixed and stained using FITC-labeled anti-V5 antibody and observed under fluorescence microscope. D, CD8 and CD4 T-cell populations of the spleen from reconstituted C57BL/6 mice with BMCs transfected using pcDNASOCS1 (SOCS1 ), pcDNASOCS3 (SOCS3 ), or control vectors (pcDNA ) after day 21 were analyzed by staining using PE-labeled anti-CD8, FITC-labeled anti-CD4, or FITC-labeled anti-V5 antibody. + T cells was presented in blood, spleen, and bone marrow of reconstituted mice with SOCS3-transfected BMCs compared with that of reconstituted mice using control pcDNA or SOCS1 structure-transfected BMCs (Fig. 1B and D and not shown) , suggesting that SOCS3 can promote BMCs to differentiate into CD8 + T cells. Indeed, in peripheral blood of reconstituted mice using SOCS3-transfected BMCs, 45% of mouse blood CD8 + T cells (Fig. 1C, C1. 3) expressed V5, a SOCS3-tagged protein, whereas only <20% of V5 + CD8 + cells was detected in peripheral blood CD8 + T cells of reconstituted mice with SOCS1 or control structure-transfected BMCs (not shown). The proportion of CD8 + V5 + cells in the spleen of reconstituted mice with SOCS3-transfected BMCs was also higher than that in the spleen of reconstituted mice with SOCS1 or control structure-transfected BMCs (Fig. 1D) . Similar to the wild mice, higher proportion of CD8 + T cells in reconstituted athymic nu/nu mice with SOCS3-transfected BMCs was also observed in blood, spleen, and bone marrow compared with controls ( Supplementary Fig. S2 ). Thus, SOCS3 likely promotes murine BMCs to differentiate into CD8 + T cells. In addition, consistent with the perspective that SOCS1 is required for the differentiation of T cells (11) , SOCS1 significantly reduced their differentiation with lower ratio of CD8 and CD4 T-cell population not only in reconstituted wild mice but also in reconstituted nu/nu athymus mice with SOCS1-transfected BMCs ( Fig. 1 and Supplementary Fig. S2 ).
Silencing or deletion of PEST-like (aa129-161) motif of SOCS3 impairs the differentiation of murine BMCs into CD8 T cells. Next, we investigated the effect of silencing SOCS3 on the differentiation of BMC into CD8 T cells. To silence SOCS3, SOCS3 siRNA template sequences were first linked into pNK-siRNA-GFP vectors, which permit coexpression of siRNA and green fluorescence protein. RT-PCR and Western blotting showed that constructed pNK-siRNA vector could decrease the transcription and expression of SOCS3 (Fig. 2A, A1 and A2) . Whereas BMCs transfected with SOCS3 siRNA structures were injected into the lethally irradiated C57BL/6, BALB/c, or athymic nu/nu mice, the proportion of CD8 T cell in peripheral blood, spleen, and bone marrow were remarkably reduced at day 21 ( Fig. 2A, A3 and not shown), indicating silencing SOCS3 indeed impaired the differentiation of BMCs into CD8 + T cells. As described above, SOCS3 significantly promotes the differentiation of BMCs into CD8 T cells, whereas SOCS1 reduced their differentiation with lower ratio of CD8 and CD4 T-cell population, implying the different role of SOCS3 versus SOCS1 in inducing the differentiation of CD8 T lymphocytes. Structure analysis of SOCS1 and SOCS3 showed that PEST-like sequence identified in SOCS3 did not occur in the same location in SOCS1 (Fig. 2B, B1) , implying a possible role of PEST-like sequences in inducing differentiation of CD8 + T cells. To determine the role of PEST-like motif in inducing CD8 + T-cell differentiation, we successfully deleted the PEST-like motif (aa129-161; SOCS3DDel129-161) and detected their effect on the differentiation of BMCs. As predicted, deletion of SOCS3 PESTlike motif (aa129-161) did influence the differentiation of BMCs with the reduced CD8 + T-cell ratio (Fig. 2B, B2) . The reduced CD8 + T-lymphocyte differentiation was also observed in other reconstituted BALB/c mice and athymus/nude mice (not shown), implying that this deletion might cause the changes of functional Figure 2 . CD8 + T-cell populations of the spleen from reconstituted C57BL/6 mice with BMCs transfected using SOCS3 siRNA or SOCS3DDel129-161 vectors. A, CD8 + T-cell populations of the spleen from reconstituted C57BL/6 mice with SOCS3 siRNA structure-transfected BMCs. Expression of SOCS3 and GAPDH transcripts in BMCs was determined by RT-PCR (A1), and protein levels of SOCS3 and actin were determined by Western blot analysis (A2); CD4 + , CD8 + , and CD4 + CD8 + cell populations (A3 ) of the spleen from reconstituted C57BL/6 mice with BMCs transfected using SOCS3 siRNA (pNKsiRNA ), mock siRNA (pNK ), or untransfected BMCs (Cont. ) after day 21 were analyzed by staining using PE-labeled anti-CD8 and FITC-labeled anti-CD4. B, CD8 T-cell populations of the spleen from reconstituted C57BL/6 mice with SOCS3DDel129-161 transfected BMCs. Functional regions of SOCS1, SOCS3, and SOCS3DDel129-161 (B1 ). CD4 + , CD8 + , and CD4 + CD8 + cell populations of the spleen from reconstituted C57BL/6 mice with SOCS3DDel129-161 (D129-161 ), pcDNASOCS3 (SOCS3 ), pcDNASOCS1 (SOCS1 ), pcDNA control vector (pcDNA ) transfected BMCs, or untransfected BMCs (Contr. ) were analyzed by using PE-labeled or FITC-labeled anti-CD8 and anti-CD4 after day 21(B2). Six mice were used per experiment group. structure region to interrupt the function of SOCS3. Indeed, the closest structure appeared in the alignments of SOCS1 to SOCS3DDel129-161, with a root mean square deviation (RMSD) of 1.91 Å over 102 residues compared with the alignment between SOCS3 and SOCS1 with an RMSD of 13.19 Å over 123 residues or SOCS3DDel129-161 and SOCS3 with the RMSD of 4.78 Å over 124 residues ( Supplementary Fig. S3 ).
Enriched accumulation of CD8 T lymphocytes appears in lung tissue of the reconstituted mice with SOCS3-transfected BMCs. SOCS3 could promote the differentiation of murine BMCs into CD8 T lymphocytes in athymus/nude mice, suggesting that SOCS3-induced CD8 T-cell differentiation is likely independent on thymus. Thus, we further investigated role of other tissues, such as bone marrow, lung, intestine, etc. Results showed that there was remarkable accumulation of CD8 T cells in lung tissues of reconstituted mice or nude mice with SOCS3-transfected BMCs ( Fig. 3 ; only data from nude mice were shown). In contrast to SOCS3, the increased cell numbers of CD8 T lymphocytes did not appear in lung tissues of those reconstituted mice with SOCS1 or control plasmid-transfected BMCs (Fig. 3) . Importantly, the flow cytometric data in Fig. 3 + T cells, and also B cells were cocultured with SOCS3-transfected BMCs. The cells from coculture were analyzed using T-cell lineage-specific markers at different time points. The proportion of CD8 + T cells in the coculture of SOCS3-transfected BMCs with lung cells was significantly higher than those of SOCS1 or pcDNA control structure-transfected BMCs (Fig. 4A ) after 14 days, further supporting that lung could be as a tissue for BMCs with up-regulated SOCS3 to differentiate into CD8 + T lymphocytes. Interestingly, higher ratio of CD8 + T cells did not be detected in the coculture of SOCS3-transfected BMCs with DC-free lung tissue (Fig. 4B and Supplementary Fig. S4A ), implying the role of DCs in inducing CD8 + T-cell differentiation. Indeed, CD8 + T-cell proportion in the coculture of SOCS3-transfected BMCs with y-like 1-expressing OP9 stromal cells (OP9DL1) was not higher than those in the control vector or SOCS1-transfected BMCs ( Supplementary  Fig. S4B ), although OP9DL1 did support T-cell differentiation (27) . Similar to thymus (reviewed in ref. 28) , lung also contains phenotypically and functionally distinct DC populations, including conventional DC (cDC) and plasmacytoid DC (pDC; Supplementary  Fig. S5 ). CD11C + MAC + macrophages were also detected (Supplementary Fig. S5 ). Further investigation found that CD8 + T-cell differentiation was mainly dependent on cDC subpopulation in lung tissue (Fig. 4B) , whereas deletion of pDC or MAC + macrophages did not cause remarkable effect on the proportion of CD8 + cell population (Fig. 4B ). In addition, DC supernatants did not induce the differentiation of CD8
+ from SOCS3-transfected BMCs, suggesting that the physical contact between BMCs and lung DCs is necessary for the generation of CD8 + T cells (Fig. 4B ). Notch1 plays a critical role in the differentiation of SOCS3-transfected BMCs into CD8 + T cells in lung tissue. The critical role of members of notch family in the differentiation of T lymphocytes suggests the possible effect of SOCS3 on the expression + , V5 + , and CD8 + V5 + T-cell population of the lung tissue from reconstituted C57BL/6 mice with SOCS3, SOCS1, or control vectors pcDNA-transfected BMCs after day 21 were analyzed by staining the expression of T-lineage markers CD4, CD8, TCRah, and V5 antibody using FITC-labeled or PE-labeled anti-CD4, CD8, TCRah, and V5 antibody. D, CD8 + cells stained using PE-labeled anti-TCRah antibody in lung tissue. Tissues were frozen in OCT compound, cut into 6-Am to 8-Am sections, collected on Frost Plus microscope slides, stained, and observed under microscopes. Six mice were used per experiment group.
of Notchs. To detect this hypothesis, we analyzed expression of Notch1, Notch2, Notch3, and Notch4 in SOCS3-transfected BMCs. The higher level of transcription and expression of Notch1 in the SOCS3-transfected BMCs could be found, although other members of Notch family, such as Notch2, Notch3, and Notch4, were not up-regulated by SOCS3 (Fig. 5A and not shown) . As controls, SOCS1 or control plasmid structure did not promote the expression of either Notch1 or Notch2, Notch3, and Notch4 ( Fig. 5A and not  shown) . Both Notch1-y-like 1 (Dll1) and Notch1-y-4 interactions condition hematopoietic progenitor differentiation by promoting T lineage and preventing B-cell development (29, 30) . We, thus, detected expression of y-like 1 and y-4 in lung tissue. As illustrated in Fig. 5B , lung tissue not only expressed y-like 1 but also y-4. This was also shown in transcriptional level (not shown).
SOCS3-transfected BMCs could express high levels of Notch1, suggesting the up-regulated Notch1 might play an important role in CD8 T-cell differentiation from BMCs. To test this, we prepared Notch1-targeted siRNA structure, which was shown to degrade Notch mRNA and decease protein level (Fig. 5C) . Whereas SOCS3 and Notch1-targeted siRNA structures were cotransfected into BMCs, Notch1-targeted siRNA abrogated the roles of SOCS3 in the differentiation of CD8 T cells from BMCs, whereas control siRNA did not have significant effect on the SOCS3-induced differentiation (Fig. 5D) . Thus, we showed that Notch1 might play a critical role in the differentiation of SOCS3-transfected BMCs into CD8 + T cells in lung tissue.
Enriched accumulation of CD8 + T lymphocytes appears in lung tissue of the mice-bearing tumor. Tumor-associated factors promote the expression of SOCS3, which induces the differentiation of BMCs into CD8 T cells. Thus, we also detected the ratio of CD8 T cells in lung tissues of mice bearing 1D8 ovarian tumor. CD8
T-cell population also remarkably accumulated in lung tissue of the mice bearing tumor (Fig. 6A) . Finally, we characterized CD8 T cells from lung tissues of SOCS3-transfected BMCs or mice bearing tumor. The isolated CD8 + T cells from lung tissue had almost similar response (Fig. 6C and D) to anti-CD3 and anti-CD28 stimulation with controls, suggesting these SOCS3-induced CD8 T cells might possess normal function.
Discussion
SOCS3 is induced and up-regulated by a number of cytokines (8) . Here, we found that some disease-associated factors, such as IL-6, LPS, and tumor-derived factors, remarkably elevate SOCS3 expression in BMCs. Interestingly, the up-regulated SOCS3 promotes differentiation of BMCs into CD8 T cells in lung tissue. Because a single naive CD8 + T-cell precursor can develop into diverse effectors and memory subsets (31), the differentiation of BMCs induced by SOCS3 into CD8 T cells may have an important significance in defense against some diseases.
Because mice lacking SOCS3 die during embryogenesis (7, 12) , using reconstituted mice with the SOCS3-transfected BMCs, we show the critical role of SOCS3 in inducing the differentiation of BMCs into CD8 + T lymphocytes. SOCS3 is also essential in the regulation of fetal liver erythropoiesis (14) , generation of Th17 differentiation (17) , differentiation of Th2 (16) , and granulopoiesis, granulocyte colony-stimulating factor receptor signaling (13) . SOCS3-deficient CD8 T cells also exhibit greater proliferation than wild-type cells in response to TCR ligation (18) . Thus, SOCS3 exerts an important role in both the differentiation of hematopoietic stem cells into T lymphocytes and granulocytes and the differentiation of T-cell subsets. The differentiation and maturity of T lymphocytes may happen outside thymus. Indeed, others also reported that, in the absence of thymus, T-cell development from the most immature progenitor stages was developed into complete maturation of ah T cells (32) . In vivo and in the absence of a thymus, y-1 or y-4 expression is sufficient to promote T-cell development from the most immature progenitor stages to complete maturation of both CD8 + and CD4 + T cells (32) (33) (34) (35) . As a significant finding, we show that lung tissues, which express y-1 and y-4, can support differentiation of BMCs into CD8 + T cells. There is also increasing evidence that hematopoietic progenitor cells may traffic from bone marrow to sites of allergen exposure in asthma and undergo in situ differentiation, contributing to ongoing airway inflammation (36) .
In vitro studies found that higher ratio of CD8 + T cells in SOCS3-transfected BMCs does not appear in coculturing with y-like 1 OP9 cells, suggesting involvement of other lung-associated factors. Indeed, there are a lot of DCs (37) that might play a role in differentiation and proliferation of CD8 + and CD4 + T cells. During thymocyte development, signals through pre-TCR induce proliferation and differentiation at early stages of maturation and, thereafter, signals through the ah receptor complex mediate the positive and negative selection and commitment to CD4 or CD8 lineage (38) . DCs orchestrate this complex process. In vitro coculture indeed suggests the roles of DCs in lung tissue in differentiation of CD8 + T cells from BMCs. Higher expression of Notch1 in the SOCS3-transfected BMCs has an important significance in differentiation and proliferation of BMCs into CD8 + T lymphocytes. Notch signaling plays multiple roles to direct diverse decisions regarding cell fate during T-cell development (34, 39, 40) . Notch receptors are present in hematopoietic precursors. Notch signaling enhances in vitro generation of human and mouse hematopoietic precursors (34) , determines T-cell or B-cell lineage specification from a common lymphoid precursor (41) (42) (43) , and promotes expansion of CD8 + cells (43) (44) (45) . Overexpression experiments have also suggested that constitutively active Notch1 biases thymocyte development toward the CD8 lineage (43, 45, 46) . We, here, increase the evidence to illustrate the difference of functional potency of SOCS3 and SOCS1. SOCS3 could promote the differentiation of CD8 T lymphocytes from BMCs, whereas SOCS1 inhibit the differentiation of these cells. SOCS1
À/À mice showed accelerated maturation of CD4 + CD8 + double-positive cells to CD4 + and CD8 + single-positive T cells, with an increased frequency of the latter (14) . Physiologically, SOCS1 is the main inducible inhibitor of IFN signaling and, in neonatal mice, prevents the establishment of a lethal inflammatory disease (47) . Mice lacking SOCS3 die during embryogenesis (12) ; however, the generation of mice conditionally deficient for SOCS3 revealed SOCS3 to be a potent physiologic suppressor of IL-6 but not IFN signaling (7, 8, 48) . SOCS1 and SOCS3 can bind Jaks, but the ability to inhibit their catalytic activity is variable (reviewed in ref. 49 ).
In conclusion, our observation suggests one mechanism that BMCs can differentiate into CD8 + T cells in athymus tissue as a response against disease-associated factors, such as tumor-derived factors ( Supplementary Fig. S6 ). These factors can elevate SOCS3 expression in BMCs. The up-regulated SOCS3 can promote differentiation of BMCs into CD8 + T cells by up-regulating Notch1 expression. Whereas BMCs with high level of Notch1 traffic into . mRNA and protein levels of murine Notch1 in pcDNASOCS3 (SOCS3 ), pcDNASOCS1 (SOCS1 ), or control vectors (pcDNA ) transfected BMCs and untransfected BMCs (Contr. ) were detected, respectively, after transfection for 24 h. Anti-Notch1 antibody (clone mN1A, Sigma) was used to detect murine Notch1. B, expression of y-like 1 and y-4 in lung tissue. Lung was stained only using secondary antibody with hematoxylin (B1) or using anti-y-like1 antibody (B2) or anti-y-4 antibody (B3 ) and then using secondary antibody with hematoxylin according to the protocol described in Materials and Methods. C, demonstration of Notch1-targeted siRNA to degrade the target mRNA. Transcription level (C1) and expression of Notch1 protein (C2 ) in the BMCs cotransfected using pcDNASOCS3 with Notch1 siRNA structure (siRNA ), BMCs cotransfected using pcDNASOCS3 with mock siRNA structure (MocksiRNA ). Contr., BMCs transfected only using SOCS3. D, silencing of Notch1 suppressed differentiation of BMCs to CD8 + T cells. BMCs cotransfected using pcDNASOCS3 with Notch1 siRNA structure (Notch1siRNA ), BMCs cotransfected using pcDNASOCS3 with mock siRNA structure (MocksiRNA ), or untransfected BMCs (Contr. ), which were cocultured with CD4 + , CD8 + T cell-free and B cell-free lung tissue cells for 14 d were analyzed by staining the expression of TCRah and CD8 using FITC-labeled or PE-labeled anti-ah or CD8 antibody.
lung tissue expressing high level of Notch1 ligand y-like 1, in which they differentiate into CD8 + T cells with biological function under the assistance of lung tissue DCs.
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